Kit containing ALL reagents (except indexes) for fusion and gene expression profiling by digital RNAseq
Target List
Covers specific sides of specific exons of the targeted genes based on the Human GRCh38 genome build.Analyzes the expression of the targeted genes.Covers specific hotspots of the targeted genes based on the Human GRCh38 genome build.
Adenocarcinomas
Non-Small Cell Carcinomas
Non-Small Cell Lung Cancers (NSCLC)
ALKBAG4BAIAP2L1BCL11ACCDC6CD74CLIP4CUX1DNAH5EGFREML4ETV6EZRFERFGFR1FGFR3GCC2GLRX5GOPCHIP1HLA-DRB1IRF2BP2KIAA1217KIF5BKLC1LRIG3MAN2A1METMPRIPNCOA4NRG1NTRK1NTRK3RAD51RETROS1RUNX1SDC4SLC34A2SLC3A2SQSTM1STRNTACC3TFGTPM3TPRTRA2BTRIM33VSNL1ALKAMER1APCATMBRAFCDKN2ACTNNB1EGFRERBB2FGFR3HRASJAK2KRASMETNFE2L2NRASPDGFRAPIK3CAPTENRETSTK11
Other Lung Cancers
Commercial Control Samples
Checkpoint Molecules
Inhibitory on T Cells
Major Histocompatibility Complex II Genes
Checkpoint Blockade Therapy Biomarkers
Immune Cell Markers
Regulatory T Cells
Myeloid Derived Suppressor Cells
Plasmacytoid Dendritic Cells
Antigen Presenting Cells
T Cell Trafficking & Infiltration into Tumors
T Cell Exhaustion
Upregulated in T Cell Exhaustion
Downregulated in T Cell Exhaustion
Responsiveness or Response Biomarkers
Enhanced Expression in Responsive Versus Nonresponsive Cancers
Suppressed Expression in Responsive Versus Nonresponsive Cancers
Differentially Expressed in Responsive Versus Nonresponsive Cancers
Expression Correlates with Positive Objective Response Rates
Regulated during Treatment
Pre-Treatment Response Prediction
Cancer Cell Killing
Inhibits Cancer Cell Killing
Stimulates Cancer Cell Killing
Antigen Processing & Presentation
Proteases
Interferon Gamma Response
RNA Degradation
Small Cell Lung Cancers
Carcinomas
Adenocarcinomas
Giant Cell Carcinomas
Lymphoepithelioma-Like Carcinomas
Mucoepidermoid Carcinomas
Squamous Cell Carcinomas (SCC)
Terminal Respiratory Unit Type Adenocarcinomas
Blastomas
Carcinosarcomas